Santos DC, Henriques RR, Junior M, Farias AB, Nogueira T, Quimas JVF, Romeiro NC, Silva LLD, Souza ALF (2020) <br />Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation<br /><i>Bioorganic & Medicinal Chemistry</i> <br /><br />Lemes LF, de Andrade Ramos G, de Oliveira AS, da Silva FM, de Castro Couto G, da Silva Boni M, Guimaraes MJ, Souza IN, Bartolini M, Andrisano V, do Nascimento Nogueira PC, Silveira ER, Brand GD, Soukup O, Korabecny J, Romeiro NC, Castro NG, Bolognesi ML, Romeiro LA (2015) <br />Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease<br /><i>Eur Journal of Medicinal Chemistry</i> <b>108</b>: 687<br /><br />Castro NG, Costa RS, Pimentel LS, Danuello A, Romeiro NC, Viegas C, Jr., Barreiro EJ, Fraga CA, Bolzani VS, Rocha MS (2008) <br />CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (-)-spectaline<br /><i>European Journal of Pharmacology</i> <b>580</b>: 339<br /><br />